California Supreme Court reverses summary judgment in Cipro pay-for-delay suit
MLex Summary: Reverse-payment settlements to delay entry of generic drugs aren’t immune from scrutiny under state antitrust laws, California’s Supreme Court ruled, reversing a lower court’s decision to dismiss a case over...To view the full article, register now.
Already a subscriber? Click here to view full article